Back to search

France· FR:68950386

ATROPINE SULFATE ACCORD 0,1 mg/mL solution injectable en seringue préremplie

A medicinal product containing sulfate d'atropine monohydraté, registered in France by ACCORD HEALTHCARE FRANCE.

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedATROPINE SULFATE ACCORD 0,1 mg/mL sol…ATC—REGISTER NO.FR:68950386PACKS LISTED1CHECKEDSeptember 12, 2026

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
SULFATE D'ATROPINE MONOHYDRATÉ
Manufacturer
ACCORD HEALTHCARE FRANCE
Country
France (FR)
ATC code
—
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

  • cip13
    3400930215234
    1 seringue(s) préremplie(s) graduées en verre de 5 ml

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Sulfate d'atropine monohydraté in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All sulfate d'atropine monohydraté products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

  • Austria · Atropin Accord, Atropinsulfat Aguettant
  • Belgium · Atropine Alcon, Atropine Sulfate Aguettant
  • Bulgaria · Атропин Вижън, Атропин Софарма
  • Cyprus · Atropine Sulfate, Atropine Αρητη
  • Czechia · Atropin Bbp, Atropin-Pos
  • Germany · Atropin Accord, Atropin-Pos
  • Denmark · Atropin Abboxia, Atropin Aguettant
  • Estonia · Atropine Auxilia, Atropine Basi
  • Spain · Atropina Accord, Atropina Aguettant
  • Finland · Atropin Abboxia, Atropin Aguettant
  • United Kingdom (Northern Ireland) · Atrophine Sulfate Wockhardt Uk, Atropine Aspire
  • Greece · Atropine Sulfate Bradex, Atropine Sulfate Cooper
  • Hungary · Atropine Sulphate Noridem, Atropinum Sulfuricum Egis
  • Ireland · Atropine Sulfate Aguettant, Minims
  • Iceland · Atropin Abboxia, Atropin Viatris
  • Italy · Atropina Farmigea, Atropina Solfato Accord
  • Liechtenstein · Ryjunea
  • Lithuania · Atropine Sulfate Basi
  • Luxembourg · Alcon, Atropine (Sulfate) Noridem
  • Latvia · Atropine Sopharma, Atropine Sulfate Basi
  • Malta · Minims
  • Netherlands · Atorvastatina Cf, Atropinesulfaat Accord
  • Norway · Atropin Abboxia, Atropin Aguettant
  • Poland · Atropinum Sulfuricum Wzf, Bellapan
  • Portugal · Atropina Accord, Atropina Aguettant
  • Romania · Sulfat De Atropină Accord, Sulfat De Atropină Evolan
  • Sweden · Atropin Abboxia, Atropin Aguettant
  • Slovakia · Atropin Bbp, Atropine Noridem

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/03ba4d21-f5f9-4524-8822-6c5d5926995e
GET /v1/drugs/03ba4d21-f5f9-4524-8822-6c5d5926995e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "68950386",
  "date_amm": "2020-10-05",
  "type_amm": "Procédure décentralisée",
  "numero_ue": null,
  "substance": "SULFATE D'ATROPINE MONOHYDRATÉ",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "solution injectable",
  "voies_administration": "intramusculaire;intraveineuse",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about sulfate d'atropine monohydraté.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.